Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

remedē System Therapy Study

NCT: NCT03884660 · ACTIVE_NOT_RECRUITING

NCT IDNCT03884660
StatusACTIVE_NOT_RECRUITING
Start Date2019-06-18
Completion2030-12-30
SponsorRespicardia, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.

Frequently Asked Questions

What is remedē System Therapy Study?

remedē System Therapy Study is a clinical trial registered under NCT03884660. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03884660?

The current status of NCT03884660 (remedē System Therapy Study) is: ACTIVE_NOT_RECRUITING.

When did remedē System Therapy Study start?

remedē System Therapy Study started on 2019-06-18.

Related Devices

PMA P160039Implanted phrenic nerve stimulator for central sleep apneaRespicardia

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑